top of page

CBD Ads Now Permitted Without Permission on Meta platforms


CBD Ads on Meta platforms

Meta, the parent company of Facebook and Instagram, has announced a new advertising policy for CBD and related products, allowing CBD ads on Meta platforms. The updated policy aims to allow people to discover and learn about these products on their platforms.


“Effective today, we are renaming our advertising policy Hemp & Related Products to CBD & Related Products and allowing the promotion of legally permissible, non-ingestible CBD in the U.S., with some restrictions.”

In addition, advertisers no longer require written permission to run ads for hemp products that do not contain CBD or more than 0.3% THC. However, these ads must comply with local laws, industry codes, and guidelines. Additionally, the new policy allows for educational, advocacy, and public service announcement ads related to CBD, as long as no prohibited products are offered for sale. It's important to note that the policy still prohibits ads promoting THC products or cannabis products with psychoactive components.


“Advertisers can only run ads that promote or offer the sale of CBD products that don’t contain more than 0.3% THC”

To run ads promoting CBD products with less than 0.3% THC, advertisers must be certified with Legitscript, obtain written permission from Meta, and comply with applicable local laws, industry codes, and guidelines. Ads targeting individuals under 18 years of age are not allowed, and CBD ads are currently restricted to the United States.


It's worth mentioning that the new policy does not affect Meta's existing policy on Prescription Drugs. Advertisers of prescription drugs must continue to comply with the specific guidelines in place for those products.


Overall, Meta's updated advertising policy reflects the company's efforts to create a more inclusive environment for CBD and related products on its platforms. The policy changes aim to strike a balance between allowing promotion and education while maintaining compliance with relevant regulations and guidelines.

Comments


2022-04-20_cbdfx_webmd-ad_v2300-x-250--Inline-Rectangle-1.png
2022-04-20_cbdfx_webmd-ad_v3728-x-90--Leaderboard.png
2022-04-20_cbdfx_webmd-ad_v2300-x-250--Inline-Rectangle-1.png
bottom of page